CGConstantine Gennatas

Constantine Gennatas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Constantine Gennatas has a total of 1 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Chromophobe renal cell carcinoma with prolonged response to targeted therapy: a case report

    by Vasiliki Michalaki, Constantine Gennatas

    Chromophobe renal cell carcinoma is universally accepted as a distinct subtype of renal cell carcinoma. There are conflicting reports on prognosis, and few data on response to treatment exist. Currently, we do not have any effective treatment for the metastatic disease apart from surgical procedures. Current strategies are based on results obtained in the context of clear cell-type renal cell carcinoma. Separate trials for rare histologies seem unfeasible and are unlikely to be performed. For these cases, clinical observations are an important part for advancing therapeutic insight. In recent years, novel tyrosine kinase inhibitors have been shown to have significant clinical benefit in advanced renal cell carcinoma.